Keyphrases
In Silico Study
100%
Type 2 Diabetic Patients
100%
Insulin Dose
100%
Artificial Pancreas
83%
Multiple Daily Injection Therapy
33%
Insulin Pump
33%
Continuous Glucose Monitoring
33%
Self-monitoring of Blood Glucose
33%
Insulin-treated
33%
Clinical Criteria
16%
Multiple Daily Injections
16%
Residual β-cell Function
16%
Monitoring Measurement
16%
Pre-screening
16%
Insulin Independence
16%
Glycemic Control
16%
Inclusion-exclusion
16%
Treatment Monitoring
16%
Patient Acceptance
16%
Clinical Outcomes
16%
Therapeutic Approaches
16%
Therapy Options
16%
Article Analysis
16%
Performance Measures
16%
Analysis Conditions
16%
Therapy Approaches
16%
Ongoing Improvement
16%
Insulin Therapy
16%
Glucose Sensor
16%
Inter-patient Variability
16%
Advanced Carbohydrate Counting
16%
Hemoglobin A1c (HbA1c)
16%
Type I Diabetes
16%
Type 1 Diabetes Patients
16%
Fast Implementation
16%
Type 1 Diabetes Mellitus (T1DM)
16%
Dependent Types
16%
Continuous Glucose Monitor
16%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
In Silico
100%
Patient with Type 2 Diabetes
100%
Self Monitoring
40%
Blood Glucose
40%
Insulin Pump
40%
Insulin Dependent Diabetes Mellitus
40%
Insulin Treatment
20%
Cell Function
20%
Patient Compliance
20%
Glycemic Control
20%
Carbohydrate Counting
20%
Beta Cell
20%
Screening
20%